1. Home
  2. CLF vs GRFS Comparison

CLF vs GRFS Comparison

Compare CLF & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cleveland-Cliffs Inc.

CLF

Cleveland-Cliffs Inc.

HOLD

Current Price

$13.75

Market Cap

7.1B

ML Signal

HOLD

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.03

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CLF
GRFS
Founded
1847
1940
Country
United States
Spain
Employees
N/A
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.1B
6.0B
IPO Year
N/A
2006

Fundamental Metrics

Financial Performance
Metric
CLF
GRFS
Price
$13.75
$9.03
Analyst Decision
Hold
Hold
Analyst Count
12
2
Target Price
$11.14
$10.15
AVG Volume (30 Days)
13.7M
569.0K
Earning Date
10-20-2025
01-01-0001
Dividend Yield
N/A
1.56%
EPS Growth
N/A
N/A
EPS
N/A
0.64
Revenue
$18,622,000,000.00
$8,821,017,248.00
Revenue This Year
$0.41
$5.36
Revenue Next Year
$7.21
$5.15
P/E Ratio
N/A
$17.84
Revenue Growth
N/A
7.31
52 Week Low
$5.63
$6.19
52 Week High
$16.70
$11.14

Technical Indicators

Market Signals
Indicator
CLF
GRFS
Relative Strength Index (RSI) 63.48 53.16
Support Level $12.82 $8.69
Resistance Level $13.33 $9.22
Average True Range (ATR) 0.51 0.18
MACD 0.10 0.03
Stochastic Oscillator 85.64 64.15

Price Performance

Historical Comparison
CLF
GRFS

About CLF Cleveland-Cliffs Inc.

Cleveland-Cliffs Inc is a flat-rolled steel producer and manufacturer of iron ore pellets in North America. It is organized into four operating segments based on differentiated products, Steelmaking, Tubular, Tooling and Stamping and European Operations, but operates through one reportable segment -Steelmaking. It is vertically integrated from mined raw materials, direct reduced iron, and ferrous scrap to primary steelmaking and downstream finishing, stamping, tooling and tubing. It serves a diverse range of other markets due to its comprehensive offering of flat-rolled steel products. Geographically, it operates in the United States, Canada and other countries. The majority of revenue is from the United States. It is a supplier of steel to the automotive industry in North America.

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

Share on Social Networks: